Akmad, Jasmin S.
HRN: 24-18-14 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
01/10/2025
01/16/2025
IV
500 Mg
Every 8 Hours
Tc Intra-amnionic Infection
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes